Trial intelligence / Profile preview

Protamine recombinant human insulin premix 30/70 vs Humulin 70/30 in type 1 or 2 diabetes (China)

CTR20150485Phase 3Completed

Sponsor
Hefei Tianhui Biotechnology
Start
Jul 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of biphasic human insulin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Hefei Tianhui Biotechnology. Started Jul 2015; status: completed.

02

Drugs

biphasic human insulin
03

Conditions

diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on CTR20150485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call